Michael J. Fox Foundation

The partnership includes biopharmaceutical, life science, and non-profit organizations, as well as several US government agencies.

The study will provide researchers, drugmakers, regulators, and payors with insight into the genetics of the disease and experience of the patients.

Using data from the Parkinson's Progression Markers Initiative, GNS Healthcare identifies genetic and molecular markers of rapid motor progression.

The study will screen patients using a combination of genotyping and wireless sensors to develop a better diagnostic method. 

NEW YORK (GenomeWeb) – The Michael J. Fox Foundation for Parkinson's Research has awarded Sok Kean Khoo, an associate professor of molecular genomics at Grand Valley State University, a $110,000 grant to study molecular biomarkers for monitoring the advancement of Parkinson's disease.

NEW YORK (GenomeWeb News) – KineMed today reported the Michael J. Fox Foundation has awarded it an additional $1.2 million to continue development of kinetic biomarkers for Parkinson's disease.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Lucigen today announced it has received a $187,000 grant from the Michael J. Fox Foundation to study a protein that has been implicated in Parkinson's disease.

A 23andMe and Parkinson's Institute team has tracked down two new risk loci for Parkinson's disease and verified many more through a web-based genome-wide association study involving more than 3,400 cases and nearly 30,000 controls.

The figure comes from a report commissioned by proteomics firm Proteome Sciences, which, like a number of other protein biomarker firms including Quanterix, Rules-Based Medicine, and NextGen Sciences, has made AD a significant focus of its R&D and commercialization efforts.

The foundation will be working with collaborators to develop assays based on two protein candidate biomarkers.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.